Literature DB >> 23746285

Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds.

Paschalia M Mountziaris1, E Dennis Lehman, Ioannis Mountziaris, David C Sing, F Kurtis Kasper, Antonios G Mikos.   

Abstract

Recent insight into the critical role of pro-inflammatory cytokines, particularly tumor necrosis factor-α (TNF-α), in bone regeneration has heralded a new direction in the design of tissue engineering constructs. Previous studies have demonstrated that continuous delivery of 50 ng/ml TNF-α to mesenchymal stem cells (MSCs) cultured on three-dimensional (3D) biodegradable electrospun poly(ϵ-caprolactone) (PCL) microfiber meshes stimulates mineralized matrix deposition, a marker of osteogenic differentiation. Since TNF-α exhibits a biphasic pattern of expression following bone fracture in vivo, this study aimed to investigate the effects of temporal patterns of TNF-α delivery on in vitro osteogenic differentiation of MSCs cultured on 3D electrospun PCL scaffolds. MSCs were cultured for 16 days and exposed to continuous, early, intermediate, or late TNF-α delivery. To further elucidate the effects of TNF-α on osteogenic differentiation, the study design included MSCs precultured both in the presence and absence of typically required osteogenic supplement dexamethasone. Mineralized matrix deposition was not observed in constructs with dexamethasone-naïve MSCs, suggesting that TNF-α is not sufficient to trigger in vitro osteogenic differentiation of MSCs. For MSCs precultured with dexamethasone, TNF-α suppressed alkaline phosphatase activity, an early marker of osteogenic differentiation, and stimulated mineralized matrix deposition, a late stage marker of MSC osteogenic differentiation. By elucidating the impact of temporal variations in TNF-α delivery on MSC osteogenic differentiation, our results offer insight into the regenerative mechanism of TNF-α and provide the design parameters for a novel tissue engineering strategy that rationally controls TNF-α signaling to stimulate bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23746285      PMCID: PMC3773264          DOI: 10.1080/09205063.2013.803455

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  37 in total

1.  Dose effect of tumor necrosis factor-alpha on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds.

Authors:  Paschalia M Mountziaris; Stephanie N Tzouanas; Antonios G Mikos
Journal:  Biomaterials       Date:  2009-12-05       Impact factor: 12.479

2.  Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha.

Authors:  Chien-Chi Lin; Andrew T Metters; Kristi S Anseth
Journal:  Biomaterials       Date:  2009-06-27       Impact factor: 12.479

Review 3.  Osteoimmunology and the effects of the immune system on bone.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Rheumatol       Date:  2009-11-03       Impact factor: 20.543

Review 4.  Trauma-induced inflammation and fracture healing.

Authors:  Hans-Christophe Pape; Ralph Marcucio; Catherine Humphrey; Celine Colnot; Matthias Knobe; Edward J Harvey
Journal:  J Orthop Trauma       Date:  2010-09       Impact factor: 2.512

Review 5.  The early fracture hematoma and its potential role in fracture healing.

Authors:  Paula Kolar; Katharina Schmidt-Bleek; Hanna Schell; Timo Gaber; Daniel Toben; Gerhard Schmidmaier; Carsten Perka; Frank Buttgereit; Georg N Duda
Journal:  Tissue Eng Part B Rev       Date:  2010-08       Impact factor: 6.389

6.  TNF-alpha promotes an odontoblastic phenotype in dental pulp cells.

Authors:  F W G Paula-Silva; A Ghosh; L A B Silva; Y L Kapila
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

7.  Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation.

Authors:  D C Lacey; P J Simmons; S E Graves; J A Hamilton
Journal:  Osteoarthritis Cartilage       Date:  2008-11-24       Impact factor: 6.576

8.  The role of lipase and alpha-amylase in the degradation of starch/poly(epsilon-caprolactone) fiber meshes and the osteogenic differentiation of cultured marrow stromal cells.

Authors:  Ana M Martins; Quynh P Pham; Patrícia B Malafaya; Rui A Sousa; Manuela E Gomes; Robert M Raphael; F Kurtis Kasper; Rui L Reis; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2009-02       Impact factor: 3.845

9.  TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway.

Authors:  Katrin Hess; Alexey Ushmorov; Jörg Fiedler; Rolf E Brenner; Thomas Wirth
Journal:  Bone       Date:  2009-05-03       Impact factor: 4.398

10.  TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.

Authors:  J Ding; O Ghali; P Lencel; O Broux; C Chauveau; J C Devedjian; P Hardouin; D Magne
Journal:  Life Sci       Date:  2009-02-03       Impact factor: 5.037

View more
  11 in total

Review 1.  Mesenchymal stem cells in the aseptic loosening of total joint replacements.

Authors:  Jukka Pajarinen; Tzu-Hua Lin; Akira Nabeshima; Eemeli Jämsen; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2017-02-01       Impact factor: 4.396

Review 2.  NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.

Authors:  T-H Lin; J Pajarinen; L Lu; A Nabeshima; L A Cordova; Z Yao; S B Goodman
Journal:  Adv Protein Chem Struct Biol       Date:  2016-12-09       Impact factor: 3.507

3.  EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210.

Authors:  Yiyan Qiu; Yang Chen; Tenghui Zeng; Weizhuang Guo; Wenyu Zhou; Xinjian Yang
Journal:  Mol Biol Rep       Date:  2016-01-16       Impact factor: 2.316

Review 4.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

5.  Tumor necrosis factor improves vascularization in osteogenic grafts engineered with human adipose-derived stem/stromal cells.

Authors:  Daphne L Hutton; Renu Kondragunta; Erika M Moore; Ben P Hung; Xiaofeng Jia; Warren L Grayson
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

6.  The influence of IL-10 and TNFα on chondrogenesis of human mesenchymal stromal cells in three-dimensional cultures.

Authors:  Michal Jagielski; Johannes Wolf; Ulrike Marzahn; Anna Völker; Marion Lemke; Carola Meier; Wolfgang Ertel; Owen Godkin; Stephan Arens; Gundula Schulze-Tanzil
Journal:  Int J Mol Sci       Date:  2014-09-09       Impact factor: 5.923

7.  Sustained delivery of recombinant human bone morphogenetic protein-2 from perlecan domain I - functionalized electrospun poly (ε-caprolactone) scaffolds for bone regeneration.

Authors:  Yu-Chieh Chiu; Eliza L Fong; Brian J Grindel; Fred K Kasper; Daniel A Harrington; Mary C Farach-Carson
Journal:  J Exp Orthop       Date:  2016-10-06

8.  Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Laura Lu; Karthik Nathan; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  Stem Cell Res Ther       Date:  2017-12-06       Impact factor: 6.832

9.  Transcriptome sequencing analysis reveals the effect of combinative treatment with low‑intensity pulsed ultrasound and magnesium ions on hFOB1.19 human osteoblast cells.

Authors:  Haiyue Zu; Xueting Yi; Dewei Zhao
Journal:  Mol Med Rep       Date:  2018-05-11       Impact factor: 2.952

10.  Parthenolide Has Negative Effects on In Vitro Enhanced Osteogenic Phenotypes by Inflammatory Cytokine TNF-α via Inhibiting JNK Signaling.

Authors:  Jin-Ho Park; Young-Hoon Kang; Sun-Chul Hwang; Se Heang Oh; June-Ho Byun
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.